{"entity":{"type":"insider","cik":"0001690319","url":"/insider/0001690319","json_url":"/insider/0001690319.json","name":"MITRANI MARIA INES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":13,"first":"2021-04-30","last":"2021-06-21","span_basis":"filed_date"},"name_variants":[{"name":"MITRANI MARIA INES","source":"filing","n_filings":13,"first_seen":"2021-04-30","last_seen":"2021-06-21"}],"transactions":[{"id":5168653,"accession":"0001683168-21-002664","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-21-002664","line_url":"/filing/0001683168-21-002664","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.13820912,"price_display":"0.14","price_state":"stated","total_value":6910.456,"total_display":"6,910.46","total_whole":"6,910","shares_owned_after":116707890.0,"shares_owned_after_display":"116,707,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider","n_lines":2},{"id":4153204,"accession":"0001683168-21-002589","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-21-002589","line_url":"/filing/0001683168-21-002589#line-3","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.161,"price_display":"0.16","price_state":"stated","total_value":8050.0,"total_display":"8,050.00","total_whole":"8,050","shares_owned_after":116757890.0,"shares_owned_after_display":"116,757,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-16","scope":"insider"},{"id":4153202,"accession":"0001683168-21-002589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-21-002589","line_url":"/filing/0001683168-21-002589#line-2","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":116807890.0,"shares_owned_after_display":"116,807,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider"},{"id":4153199,"accession":"0001683168-21-002589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-002589","line_url":"/filing/0001683168-21-002589#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":7000.0,"total_display":"7,000.00","total_whole":"7,000","shares_owned_after":116857890.0,"shares_owned_after_display":"116,857,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":5444669,"accession":"0001683168-21-002505","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001683168-21-002505","line_url":"/filing/0001683168-21-002505","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49910.0,"shares_display":"49,910","price_per_share":0.1388595872570627,"price_display":"0.14","price_state":"stated","total_value":6930.482,"total_display":"6,930.48","total_whole":"6,930","shares_owned_after":116907890.0,"shares_owned_after_display":"116,907,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-11","scope":"insider","n_lines":2},{"id":5444664,"accession":"0001683168-21-002505","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001683168-21-002505","line_url":"/filing/0001683168-21-002505","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85200.0,"shares_display":"85,200","price_per_share":0.1411737089201878,"price_display":"0.14","price_state":"stated","total_value":12028.0,"total_display":"12,028.00","total_whole":"12,028","shares_owned_after":116993000.0,"shares_owned_after_display":"116,993,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider","n_lines":2},{"id":5444659,"accession":"0001683168-21-002505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-21-002505","line_url":"/filing/0001683168-21-002505","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":0.1525,"price_display":"0.15","price_state":"stated","total_value":12200.0,"total_display":"12,200.00","total_whole":"12,200","shares_owned_after":117073000.0,"shares_owned_after_display":"117,073,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider","n_lines":2},{"id":4280658,"accession":"0001683168-21-002429","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001683168-21-002429","line_url":"/filing/0001683168-21-002429","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.134,"price_display":"0.13","price_state":"stated","total_value":13400.0,"total_display":"13,400.00","total_whole":"13,400","shares_owned_after":117123000.0,"shares_owned_after_display":"117,123,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-08","scope":"insider","n_lines":2},{"id":4280651,"accession":"0001683168-21-002429","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001683168-21-002429","line_url":"/filing/0001683168-21-002429","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.1235,"price_display":"0.12","price_state":"stated","total_value":12350.0,"total_display":"12,350.00","total_whole":"12,350","shares_owned_after":117223000.0,"shares_owned_after_display":"117,223,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-08","scope":"insider","n_lines":2},{"id":4280646,"accession":"0001683168-21-002429","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-21-002429","line_url":"/filing/0001683168-21-002429","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.1388,"price_display":"0.14","price_state":"stated","total_value":13880.0,"total_display":"13,880.00","total_whole":"13,880","shares_owned_after":117373000.0,"shares_owned_after_display":"117,373,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-08","scope":"insider","n_lines":3},{"id":5123936,"accession":"0001683168-21-002361","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001683168-21-002361","line_url":"/filing/0001683168-21-002361","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":0.1658024777777778,"price_display":"0.17","price_state":"stated","total_value":14922.223,"total_display":"14,922.22","total_whole":"14,922","shares_owned_after":117463000.0,"shares_owned_after_display":"117,463,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-03","scope":"insider","n_lines":3},{"id":5123933,"accession":"0001683168-21-002361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-002361","line_url":"/filing/0001683168-21-002361#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.192,"price_display":"0.19","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","total_whole":"9,600","shares_owned_after":117513000.0,"shares_owned_after_display":"117,513,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":5383590,"accession":"0001683168-21-002285","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001683168-21-002285","line_url":"/filing/0001683168-21-002285#line-4","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.183,"price_display":"0.18","price_state":"stated","total_value":9150.0,"total_display":"9,150.00","total_whole":"9,150","shares_owned_after":117563000.0,"shares_owned_after_display":"117,563,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-05-28","scope":"insider"},{"id":5383588,"accession":"0001683168-21-002285","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-21-002285","line_url":"/filing/0001683168-21-002285","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":117663000.0,"shares_owned_after_display":"117,663,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-28","scope":"insider","n_lines":2},{"id":5383585,"accession":"0001683168-21-002285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-002285","line_url":"/filing/0001683168-21-002285#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.193,"price_display":"0.19","price_state":"stated","total_value":7720.0,"total_display":"7,720.00","total_whole":"7,720","shares_owned_after":117713000.0,"shares_owned_after_display":"117,713,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-28","scope":"insider"},{"id":4835397,"accession":"0001683168-21-002230","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001683168-21-002230","line_url":"/filing/0001683168-21-002230","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.1975,"price_display":"0.20","price_state":"stated","total_value":19750.0,"total_display":"19,750.00","total_whole":"19,750","shares_owned_after":117753000.0,"shares_owned_after_display":"117,753,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-25","scope":"insider","n_lines":2},{"id":4835390,"accession":"0001683168-21-002230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-21-002230","line_url":"/filing/0001683168-21-002230#line-2","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":117853000.0,"shares_owned_after_display":"117,853,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-25","scope":"insider"},{"id":4835383,"accession":"0001683168-21-002230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-002230","line_url":"/filing/0001683168-21-002230#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":117903000.0,"shares_owned_after_display":"117,903,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-25","scope":"insider"},{"id":5123930,"accession":"0001683168-21-002141","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001683168-21-002141","line_url":"/filing/0001683168-21-002141","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.1915,"price_display":"0.19","price_state":"stated","total_value":19150.0,"total_display":"19,150.00","total_whole":"19,150","shares_owned_after":118003000.0,"shares_owned_after_display":"118,003,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-20","scope":"insider","n_lines":2},{"id":5123928,"accession":"0001683168-21-002141","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-21-002141","line_url":"/filing/0001683168-21-002141","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102000.0,"shares_display":"102,000","price_per_share":0.20107843137254902,"price_display":"0.20","price_state":"stated","total_value":20510.0,"total_display":"20,510.00","total_whole":"20,510","shares_owned_after":118053000.0,"shares_owned_after_display":"118,053,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-20","scope":"insider","n_lines":2},{"id":5123926,"accession":"0001683168-21-002141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-002141","line_url":"/filing/0001683168-21-002141#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":11000.0,"total_display":"11,000.00","total_whole":"11,000","shares_owned_after":118155000.0,"shares_owned_after_display":"118,155,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":4702735,"accession":"0001683168-21-002076","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001683168-21-002076","line_url":"/filing/0001683168-21-002076","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":0.20339333333333334,"price_display":"0.20","price_state":"stated","total_value":15254.5,"total_display":"15,254.50","total_whole":"15,255","shares_owned_after":118230000.0,"shares_owned_after_display":"118,230,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-17","scope":"insider","n_lines":3},{"id":4702718,"accession":"0001683168-21-002076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-21-002076","line_url":"/filing/0001683168-21-002076#line-2","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.24,"price_display":"0.24","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":118280000.0,"shares_owned_after_display":"118,280,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-17","scope":"insider"},{"id":4702715,"accession":"0001683168-21-002076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-002076","line_url":"/filing/0001683168-21-002076#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":13500.0,"total_display":"13,500.00","total_whole":"13,500","shares_owned_after":118330000.0,"shares_owned_after_display":"118,330,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-17","scope":"insider"},{"id":5268602,"accession":"0001683168-21-001932","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001683168-21-001932","line_url":"/filing/0001683168-21-001932#line-5","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.261,"price_display":"0.26","price_state":"stated","total_value":13050.0,"total_display":"13,050.00","total_whole":"13,050","shares_owned_after":118380000.0,"shares_owned_after_display":"118,380,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-12","scope":"insider"},{"id":5268601,"accession":"0001683168-21-001932","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001683168-21-001932","line_url":"/filing/0001683168-21-001932","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":0.32142893333333333,"price_display":"0.32","price_state":"stated","total_value":24107.17,"total_display":"24,107.17","total_whole":"24,107","shares_owned_after":118463217.0,"shares_owned_after_display":"118,463,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider","n_lines":3},{"id":5268595,"accession":"0001683168-21-001932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-001932","line_url":"/filing/0001683168-21-001932#line-1","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.271,"price_display":"0.27","price_state":"stated","total_value":13550.0,"total_display":"13,550.00","total_whole":"13,550","shares_owned_after":118505000.0,"shares_owned_after_display":"118,505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-10","filed_date":"2021-05-12","scope":"insider"},{"id":5533952,"accession":"0001683168-21-001825","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001683168-21-001825","line_url":"/filing/0001683168-21-001825","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":0.265,"price_display":"0.26","price_state":"stated","total_value":21200.0,"total_display":"21,200.00","total_whole":"21,200","shares_owned_after":118555000.0,"shares_owned_after_display":"118,555,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-07","filed_date":"2021-05-07","scope":"insider","n_lines":2},{"id":5533946,"accession":"0001683168-21-001825","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-21-001825","line_url":"/filing/0001683168-21-001825#line-3","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":10400.0,"total_display":"10,400.00","total_whole":"10,400","shares_owned_after":118635000.0,"shares_owned_after_display":"118,635,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-07","scope":"insider"},{"id":5533943,"accession":"0001683168-21-001825","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001683168-21-001825","line_url":"/filing/0001683168-21-001825","is_derivative":false,"issuer_cik":"0001557376","issuer_name":"Organicell Regenerative Medicine, Inc.","issuer_ticker":"BPSR","issuer_name_source":null,"issuer_url":"/issuer/0001557376","owner_cik":"0001690319","owner_name":"MITRANI MARIA INES","owner_display_name":"MITRANI MARIA INES","owner_url":"/insider/0001690319","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":0.298,"price_display":"0.30","price_state":"stated","total_value":22350.0,"total_display":"22,350.00","total_whole":"22,350","shares_owned_after":118700000.0,"shares_owned_after_display":"118,700,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-05-05|5533941","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":52,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557376","name":"Organicell Regenerative Medicine, Inc.","url":"/issuer/0001557376","role":"Officer (Chief Science Officer)","n_filings":13,"first_seen":"2021-04-30","last_seen":"2021-06-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001690319","retrieved_at":"2026-08-24T00:13:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}